Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningiomaMasahiro Yamamoto, Chifumi Kitanaka, Hajime Yonezawa et al.|Neuro-Oncology|2021Cited by 26
ET-7 Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningiomaMasahiro Yamamoto, Chifumi Kitanaka, Hiroyuki Uchida et al.|Neuro-Oncology Advances|2021Cited by 0